glp-1 kidney protection and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 agonists in the treatment
Description
Contribution statement Both authors wrote and edited the manuscript and approved the final version
, Dray, C
12, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice
The nonpartisan health policy organization KFF estimates that more than 31 million American adults use a GLP-1 medication
To estimate the number of people worldwide with obesity, we also used 2016 population data for adult men and women from each country from the World Bank
Incapsula incident ID: 984000070535030647-269606113825522152
